Conformational Asn187Asp/Lys antithrombin variants and thrombosis

Véronique Picard; Anne Bauters; Mahnouch Khairy; Nadège Ochat; Brigitte Jude; Martine Aiach; Martine Alhenc-Gelas

doi:10.1160/TH04-08-0477

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 93(01): 57-62
DOI: 10.1160/TH04-08-0477

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Conformational Asn187Asp/Lys antithrombin variants and thrombosis

Clinical and biological features in 13 new heterozygotes

Véronique Picard

¹Service d’Hématologie Biologique A, Hôpital Européen Georges Pompidou, Paris, France

²Laboratoire d’Hématologie, UFR de Pharmacie, Université Paris XI, Châtenay-Malabry, France

,

Anne Bauters

³Institut d’Hématologie Biologique, Centre Hospitalier Régional Universitaire, Lille, France

,

Mahnouch Khairy

²Laboratoire d’Hématologie, UFR de Pharmacie, Université Paris XI, Châtenay-Malabry, France

,

Nadège Ochat

¹Service d’Hématologie Biologique A, Hôpital Européen Georges Pompidou, Paris, France

,

Brigitte Jude

³Institut d’Hématologie Biologique, Centre Hospitalier Régional Universitaire, Lille, France

,

Martine Aiach

¹Service d’Hématologie Biologique A, Hôpital Européen Georges Pompidou, Paris, France

,

Martine Alhenc-Gelas

¹Service d’Hématologie Biologique A, Hôpital Européen Georges Pompidou, Paris, France

› Author Affiliations

Abstract

Full Text

PDF Download

Keywords

Antithrombin - conformational variant - thrombophilia - serpin

References

References
1 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-30.
2 Heijboer H, Brandjes DP, Buller HR. et al Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-6.
3 Rosendaal FR. Risks factors for venous thrombotic disease. Thromb Haemost 1996; 82: 616-9.
4 Tait RC, Walker ID, Perry DJ. et al Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-12.
5 Lane DA, Bayston T, Olds RJ. et al Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
6 Perry DJ, Marshall C, Borg JY. et al Two novel antithrombin variants, Asn187Asp and Asn187Lys, indicate a functional role for asparagine 187. Blood Coagul Fibrinolysis 1995; 6: 51-4.
7 Bruce D, Perry DJ, Borg JY. et al Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn → Asp). J Clin Invest 1994; 94: 2265-74.
8 Beauchamp NJ, Pike RN, Daly M. et al Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. Blood 1998; 92: 2696-706.
9 Picard V, Dautzenberg MD, Villoutreix BO. et al Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis. Blood 2003; 102: 919-25.
10 Creagh MD, Roberts IF, Clark DJ. et al Familial antithrombin III deficiency and Mycoplasma pneumoniae pneumonia. J Clin Pathol 1991; 44: 870-1.
11 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
12 Picard V, Bura A, Emmerich J. et al Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene. Br J Haematol 2000; 110: 731-4.
13 Sas G, Pepper DS, Cash JD. Plasma and serum antithrombin III: differentiation by crossed immunoelectrophoresis. Thromb Res 1975; 6: 87-91.
14 Picard V, Marque PE, Paolucci F. et al Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin. J Biol Chem 1999; 274: 4586-93.
15 McKay EJ. A simple two-step procedure for the isolation of antithrombin III from biological fluids. Thromb Res 1981; 21: 375-82.
16 Wardell MR, Chang WS, Bruce D. et al Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Biochemistry 1997; 36: 13133-42.
17 Carrell RW, Huntington JA, Mushunje A. et al The conformational basis of thrombosis. Thromb Haemost 2001; 86: 14-22.
18 Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001; 86: 104-11.
19 Martinelli I, Legnani C, Bucciarelli P. et al Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-3.
20 Conard J, Horellou MH, Van Dreden P. et al Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost 1990; 63: 319-20.
21 Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. Arterioscler Thromb Vasc Biol 1996; 16: 742-8.
22 Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000; 53: 573-80.
23 Hellgren M. Hemostasis during normal pregnancy and the puerperium. Semin Thromb Hemost 2003; 2: 125-30.
24 Eichinger S, Weltermann A, Philipp K. et al Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999; 82: 1232-6.
25 Irving JA, Pike RN, Lesk AM. et al Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res 2000; 10: 1845-64.
26 Gettins PG. The F-helix of serpins plays an essential, active role in the proteinase inhibition mechanism. FEBS Lett 2002; 523: 2-6.
27 Schreuder HA, de Boer B, Dijkema R. et al The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat Struct Biol 1994; 1: 48-54.